Ulipristal是一种选择性的孕酮受体调节剂(SPRM),用于无保护措施性交或避孕失败后的紧急避孕。
Ulipristal is a selective SPRM for emergency contraception after an unprotected intercourse or contraceptive failure.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Attardi BJ, et al. J Steroid Biochem Mol Biol, 2004, 88(3), 277-288.
分子式 C30H37NO4 |
分子量 475.62 |
CAS号 159811-51-5 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 80 mg/mL |
Water <1 mg/mL |
Ethanol 12 mg/mL |
体内溶解度
NCT02213081 | Endometriosis | Drug: Ulipristal | Northwestern University | Phase 4 | 2015-02-01 | 2016-09-27 |
NCT02517463 | Contraception | Drug: Ulipristal acetate | The University of Hong Kong|The Family Planning Association of Hong Kong | 2011-05-01 | 2015-08-04 | |
NCT02922127 | Contraception | Drug: Ulipristal Acetate|Drug: Combined Oral Contraceptive Pill | Columbia University|Weill Medical College of Cornell University|Memorial Sloan Kettering Cancer Center | Phase 1 | 2016-12-16 | 2017-02-06 |
NCT02634437 | Renal Function | Drug: Ulipristal acetate | Forest Laboratories | Phase 1 | 2015-12-01 | 2016-09-07 |
NCT02601196 | Women With Leiomyoma After at Least One Unsuccessful IVF Treatment | Drug: Ulipristal acetate | Sheba Medical Center | Phase 4 | 2016-09-01 | 2016-07-10 |
NCT02361905 | Fibroid | Drug: ulipristal acetate|Drug: Leuprolide acetate | University Magna Graecia | Phase 4 | 2015-02-01 | 2016-11-17 |
NCT01391845 | Infertility | Drug: ulipristal acetate|Drug: placebo|Drug: ulipristal acetate|Drug: placebo | Programa de Asistencia Reproductiva de Rosario | 2011-07-01 | 2011-07-19 | |
NCT02361879 | Fibroid | Drug: ulipristal acetate|Drug: Leuprolide acetate | University Magna Graecia | Phase 4 | 2015-02-01 | 2016-11-17 |
NCT02451826 | Ovulation Inhibition | Drug: Ulipristal acetate | Population Council | Phase 1|Phase 2 | 2015-05-01 | 2016-05-27 |
NCT02825719 | Fibroid | Drug: Ulipristal acetate|Other: Placebo pills|Drug: Ferrous sulphate|Drug: Tranexamic Acid | Queen Mary Hospital, Hong Kong | Phase 4 | 2015-11-01 | 2017-01-30 |
NCT00290251 | Leiomyoma | Drug: ulipristal acetate|Drug: ulipristal acetate|Drug: placebo | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|HRA Pharma|National Institutes of Health Clinical Center (CC) | Phase 2 | 2006-02-01 | 2012-11-14 |
NCT02587000 | Adenomyosis | Drug: Ulipristal acetate|Drug: Placebo | Assistance Publique - H么pitaux de Paris|Gedeon Richter Ltd. | Phase 2 | 2015-05-01 | 2017-03-21 |
NCT02288130 | Fibroids | Drug: GnRHa|Drug: Ulipristal | VU University Medical Center | Phase 4 | 2014-12-01 | 2016-11-02 |
NCT02357563 | Fibroid | Drug: ulipristal acetate|Drug: Leuprolide acetate | University Magna Graecia | Phase 4 | 2015-02-01 | 2016-11-17 |
NCT01953679 | Focus: Estrogen-free Oral Contraception | Drug: Ulipristal Acetate | Health Decisions|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 2 | 2014-03-01 | 2016-02-19 |
NCT02147197 | Uterine Bleeding in Women With Leiomyomas | Drug: Ulipristal acetate 5 mg|Drug: Ulipristal acetate 10 mg|Drug: Placebo | Watson Pharmaceuticals | Phase 3 | 2014-04-01 | 2017-03-16 |
NCT01642472 | Uterine Fibroids | Drug: Ulipristal Acetate - open label | PregLem SA | Phase 3 | 2012-07-01 | 2016-01-07 |
NCT01553123 | Leiomyomas | Drug: Ulipristal Acetate|Drug: Iron | Watson Pharmaceuticals | Phase 3 | 2012-04-01 | 2013-02-05 |
NCT01569737 | Emergency Contraception | Drug: ella | HRA Pharma | 2012-01-01 | 2014-09-18 | |
NCT02361892 | Infertility | Drug: ulipristal acetate | University Magna Graecia | Phase 4 | 2015-02-01 | 2016-11-17 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们